Skip to main content
SpringerLink
Log in

Implantable Cardioverter-Defibrillators

  • Chapter
Contemporary Concepts in Cardiology

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 217))

  • 93 Accesses

Abstract

In those patients whose malignant ventricular arrhythmia are not controlled by medications, an implanted device capable of detecting and treating VT or VF is the remaining therapeutic option. Such a device is also often used as primary therapy for malignant ventricular arrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mirowski M. The implantable cardioverter-defibrillator: an update. J Cardiovasc Med 1984: 9: 191.

    Google Scholar 

  2. Mitrani R, et al. Current trends in the implantable cardioverter-defibrillator. In: D. Zipes and J. Jalife, eds. Cardiac Electrophysiology From Cell to Bedside. Philadelphia: W.B. Saunders Co., 1995: 1393.

    Google Scholar 

  3. Brooks R, et al. Successful implantation of cardioverter-defibrillator systems in patients with elevated defibrillation thresholds. J Am Coll Cardiol 1993: 22: 569.

    Article  PubMed  CAS  Google Scholar 

  4. CPI. data on file.

    Google Scholar 

  5. Raviele A, Gasparini G. Italian multicenter clinical experience with endocardial defibrillation: acute and long-term results in 307 patients. PACE 1995: 18: 599.

    Article  PubMed  CAS  Google Scholar 

  6. Bardy G, et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993: 88: 543.

    Article  PubMed  CAS  Google Scholar 

  7. Fisher J, et al. Comparative effectiveness of pacing techniques for termination of well-tolerated sustained ventricular tachycardia. PACE 1983: 6: 915.

    Article  PubMed  CAS  Google Scholar 

  8. Dillon SM, et al. Effects of overdrive stimulation on functional reentrant circuits causing ventricular tachycardia in the canine heart: mechanisms for resumption or alteration of tachycardia. J Cardiovasc Electrophysiol 1993:4:393. ai]9._Waldecker B, et al. Overdrive stimulation of functional reentrant circuits causing ventricular tachycardia in the infarcted canine heart. Resetting and entrainment. Circulation 1993:87:1286.

    Article  PubMed  CAS  Google Scholar 

  9. Schmidinger H, Sowten E. Physiological variation in the termination window of reentry tachycardia studied by non-invasive programmed stimulation. European Heart Journal 1988: 9: 997.

    PubMed  CAS  Google Scholar 

  10. Waldecker B, et al. Importance of modes of electrical termination of ventricular tachycardia for the selection of implantable antitachycardia devices. Am J Cardiol 1986: 57: 150.

    Article  PubMed  CAS  Google Scholar 

  11. Ventritex. data on file.

    Google Scholar 

  12. Medtronic, data on file.

    Google Scholar 

  13. Zipes D, et al. Clinical transvenous cardioversion of recurrent life-threatening ventricular arrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 1982: 103: 789.

    Article  PubMed  CAS  Google Scholar 

  14. Waspe L, et al. Role of a catheter lead system for transvenous countershock and pacing during electrophysiologic tests: An assessment of the usefulness of catheter shocks for terminating ventricular tachyarrhythmias. Am J Cardiol 1983: 52: 477.

    Article  PubMed  CAS  Google Scholar 

  15. Saksena S, et al. Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: A prospective, randomized, crossover study. Circulation 1985: 72: 153.

    Article  PubMed  CAS  Google Scholar 

  16. Siebels J, Schneider M, Kuck K. Low energy cardioversion with the implantable cardioversion deibrillator devices for treatment of vetnricular tachycardia and ventricular fibrillation. Zeitschrift fuer Kardiologie 1993: 82: 683.

    CAS  Google Scholar 

  17. Zipes D, et al. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol 1975: 36: 37.

    Article  PubMed  CAS  Google Scholar 

  18. Pruente HM, et al. Animated images of cardiac membrane voltage during defibrillation. J Electrocardiol 1995: 28 (Suppl): 7.

    Article  PubMed  Google Scholar 

  19. Chen P-S, et al. Comparison of defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986: 73: 1022.

    Article  PubMed  CAS  Google Scholar 

  20. Shibata N, et al. Epicardial activation after unsuccessful defibrillation in dogs. Am J Physiol 1988: 255: H902.

    PubMed  CAS  Google Scholar 

  21. Troup P. Implantable cardioverters and defibrillators. Curr Probl in Cardiol. Vol. IV(12). Chicago: Med Publishers, 1989: 675.

    Google Scholar 

  22. Saksena S, et al. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992: 70: 304.

    Article  PubMed  CAS  Google Scholar 

  23. Wyse D, et al. Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am J Cardiol 1993: 71: 197.

    Article  PubMed  CAS  Google Scholar 

  24. Winkle R, et al. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J 1989: 117: 122.

    Article  PubMed  CAS  Google Scholar 

  25. Bardy G, et al. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989: 14: 728.

    Article  PubMed  CAS  Google Scholar 

  26. Bardy G, et al. Electrode system influence on biphasic waveform defibrillation efficacy in humans. Circulation 1991: 84: 665.

    Article  PubMed  CAS  Google Scholar 

  27. Bardy G, et al. Prospective comparison of sequential pulse and single pulse defibrillation with use of two different clinically available systems. J Am Coll Cardiol 1989: 14: 165.

    Article  PubMed  CAS  Google Scholar 

  28. Hook B, et al. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Circulation 1993: 87: 1897.

    Article  PubMed  CAS  Google Scholar 

  29. Hurwitz J, et al. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 1993: 21: 895.

    Article  PubMed  CAS  Google Scholar 

  30. Mosteller R, et al. Operative mortality with implantation of the automatic cardioverter-defibrillator. Am J Cardiol 1991: 68: 1340.

    Article  PubMed  CAS  Google Scholar 

  31. Autschbach R, et al. The effect of coronary bypass graft surgery for the prevention of sudden cardiac death: recurrent episodes after ICD implantation and review of literature. PACE 1994: 17: 552.

    Article  PubMed  CAS  Google Scholar 

  32. Singer I, Lang D. Defibrillation threshold: clinical utility and therapeutic implications. PACE 1992: 15: 923.

    Article  Google Scholar 

  33. Singer I, et al. Is defibrillation testing safe? Pacing and Cardiac Electrophysiology 1991: 14: 1899.

    CAS  Google Scholar 

  34. Cardiac Pacemakers I. Endotak, Clinical Summary Report. St. Paul, MN: Cardiac Pacemakers, Inc., 1993

    Google Scholar 

  35. Joye J, et al. Perioperative morbidity and mortality after ICD implantation in 150 consecutive patients. Circulation 1991: 84: II–608.

    Google Scholar 

  36. Levine J, et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter defibrillators. Circulation 1991: 84: 558.

    Article  PubMed  CAS  Google Scholar 

  37. Goodman L, et al. Complications of automatic implantable cardioverter-defibrillators: Radiographic, CT and echocardiographic evaluation. Radiology 1989: 170: 447.

    PubMed  CAS  Google Scholar 

  38. Spotnitz H, et al. Methods of ICD-pacemaker insertion to avoid interactions. Ann Thorac Surg 1992: 53: 253.

    Article  PubMed  CAS  Google Scholar 

  39. Reiffel J, Coromilas J, Zimmerman J. Drug-device interactions: Clinical considerations. PACE 1985: 8: 369.

    Article  PubMed  CAS  Google Scholar 

  40. Epstein A, et al. Clinical characteristics and outcome of patients with high defibrillation thresholds. A muti-center study. Circulation 1992: 86: 1206.

    Article  PubMed  CAS  Google Scholar 

  41. Woolfolk D, et al. The effect of quinidine on electrical energy required for ventricular defibrillation. Am Heart J 1966: 72: 659.

    Article  PubMed  CAS  Google Scholar 

  42. Dawson A, Steinberg M, Shapland J. Effect of class I and class III drugs on current and energy required for internal defibrillation. Circulation 1985: 72(Suppl III): 384.

    Google Scholar 

  43. Manz M, Jung W, Luderitz B. Interactions between drugs and devices: experimental and clinical studies. Am Heart J 1994: 127: 978.

    Article  PubMed  CAS  Google Scholar 

  44. Echt D, et al. Effect of lidocaine on defibrillation energy requirements in patients (abstract). Circulation 1989: 80: II224.

    Article  Google Scholar 

  45. Echt D, Cato E, Coxe D. pH-dependent effects of lidocaine on defibrillation energy requirements in dogs. Circulation 1989: 80: 1003.

    Article  PubMed  CAS  Google Scholar 

  46. Marinchak R, et al. Effect of antiarrhythmic drugs on defibrillation threshold: Case report of an adverse effect of mexiletine and review of the literature. PACE 1988: 11: 7.

    Article  PubMed  CAS  Google Scholar 

  47. Ruffy R, et al. Adrenergically mediated variations in the energy required to defibrillate the heart: observations in closed-chest, nonanesthetized dogs. Circulation 1986: 73: 374.

    Article  PubMed  CAS  Google Scholar 

  48. Huang S, et al. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator. Am Heart J 1991: 122: 720.

    Article  PubMed  CAS  Google Scholar 

  49. Fain E, Lee J, Winkle R. Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements. Am Heart J 1987: 114: 8.

    Article  PubMed  CAS  Google Scholar 

  50. Dorian P, et al. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model. Circulation 1991: 83: 614.

    Article  PubMed  CAS  Google Scholar 

  51. Echt D, et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs: sodium channel block and action potential prolongation. Circulation 1989: 79: 1106.

    Article  PubMed  CAS  Google Scholar 

  52. Wang M, Dorian P. DL and D sotalol decrease defibrillation energy requirements. PACE 1989: 12: 1522.

    Article  PubMed  CAS  Google Scholar 

  53. Schrader R, et al. Verapamil increases the internal defibrillation energy requirements in anesthetized dogs. J Cardiovasc Pharmacol 1992: 19: 839.

    Article  PubMed  CAS  Google Scholar 

  54. Pinski S, et al. Patients with a high defibrillation threshold: Clinical characteristics, management and outcome. Am Heart J 1991: 122: 89.

    Article  PubMed  CAS  Google Scholar 

  55. Morris P, et al. Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics 1991: 31: 58.

    Article  Google Scholar 

  56. Fricchione G, Olson L, Vlay S. Psychiatric syndromes in patients with the automatic implantable cardioverter defibrillator: Anxiety, psychological dependence, abuse, and withdrawal. Am Heart J 1989: 117: 1411.

    Article  PubMed  CAS  Google Scholar 

  57. Tchou P, et al. Psychological support and psychiatric management of patients with automat ic implantable cardioverter defibrillator. Int J Psych Med 1989: 19: 393.

    Article  CAS  Google Scholar 

  58. Dreifus L, et al. Guidelines for implantation of cardiac pacemakers and antitachyarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 1992: 18: 1.

    Google Scholar 

  59. Lehmann M, Saksena S. Implantable cardioverter defibrillator in cardiovascular practice: report of the Policy Conference of the North American Society of Pacing and Electrophysiology. NASPE Policy Conference Committee. PACE 1991: 14: 969.

    Article  PubMed  CAS  Google Scholar 

  60. Mirowski M, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983: 98: 585.

    PubMed  CAS  Google Scholar 

  61. Veltri E, et al. Followup of patients with ventricular tachyarrhythmia treated with the automatic implantable cardioverter-defibrillator: programmed electrical stimulation results do not predict clinical outcome. J Electrophysiol 1989: 3: 467.

    Google Scholar 

  62. Tchou P, et al. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 1988: 109: 529.

    PubMed  CAS  Google Scholar 

  63. Marchlinski F, et al. The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures. Ann Intern Med 1986: 104: 481.

    PubMed  CAS  Google Scholar 

  64. Kelly P, et al. The automatic implantable cardioverter-defibrillator: efficacy, complications, and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988: 11: 1278.

    Article  PubMed  CAS  Google Scholar 

  65. Forgoros R, Elson J, Bonnet C. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. J Am Coll Cardiol 1989: 14: 508.

    Article  Google Scholar 

  66. Myerburg R, et al. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989: 14: 508.

    Article  PubMed  CAS  Google Scholar 

  67. Wever E, et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995: 91: 2195.

    Article  PubMed  CAS  Google Scholar 

  68. Siebels J, Kuck K. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994: 127: 1139.

    Article  PubMed  CAS  Google Scholar 

  69. Connolly S, et al. Canadian Implantable Defibrillator Study (CIDS): study design and organization. Am J Cardiol 1993: 72: 103F.

    Article  PubMed  CAS  Google Scholar 

  70. Saxon L, et al. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J 1995: 130: 501.

    Article  PubMed  CAS  Google Scholar 

  71. Sweeney M, et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 1995: 92: 3273.

    Article  PubMed  CAS  Google Scholar 

  72. Grimm M, et al. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation. J Thorac Cardiovasc Surg 1995: 110: 532.

    Article  PubMed  CAS  Google Scholar 

  73. Kupperman M, et al. An analysis of the cost effectiveness of the implantable defibrillator. Circulation 1990: 81: 91.

    Article  Google Scholar 

  74. O’Donoghue S, et al. Automatic implantable cardioverter-defibrillator: Is early implantation cost-effective? J Am Coll Cardiol 1990: 16: 1258.

    Article  PubMed  Google Scholar 

  75. Larsen G, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992: 19: 1323.

    Article  PubMed  CAS  Google Scholar 

  76. Kupersmith J, et al. Evaluating and improving the cost-effectiveness of the implantable defibrillator. Am Heart J 1995: 130: 507.

    Article  PubMed  CAS  Google Scholar 

  77. Wever E, et al. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors A randomized study. Circulation 1996: 93: 489.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Leslie J. Lipka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Coromilas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lipka, L.J., Coromilas, J. (1999). Implantable Cardioverter-Defibrillators. In: Contemporary Concepts in Cardiology. Developments in Cardiovascular Medicine, vol 217. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5007-5_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5007-5_36

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7274-5

  • Online ISBN: 978-1-4615-5007-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation